Guanze Medical Information Industry (Holding) Co., Ltd. (HKG:2427)
Hong Kong
· Delayed Price · Currency is HKD 3.540
0.00 (0.00%)
Last updated: Mar 10, 2026, 10:22 AM HKT
HKG:2427 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 |
| Revenue | 147.57 | 155.74 | 156.07 | 177.11 | 211.08 | 184.44 | Upgrade
|
| Revenue Growth (YoY) | 21.26% | -0.21% | -11.88% | -16.09% | 14.45% | 30.97% | Upgrade
|
| Cost of Revenue | 93.28 | 92.95 | 70.67 | 96.14 | 135.38 | 122.45 | Upgrade
|
| Gross Profit | 54.29 | 62.79 | 85.41 | 80.98 | 75.7 | 61.98 | Upgrade
|
| Selling, General & Admin | 28.76 | 31.57 | 40.9 | 32.55 | 33.19 | 20.84 | Upgrade
|
| Research & Development | 4.83 | 4.07 | 1.53 | 0.54 | 0.4 | 1.19 | Upgrade
|
| Other Operating Expenses | - | - | - | - | - | 0.79 | Upgrade
|
| Operating Expenses | 34.05 | 38.83 | 46.7 | 33.29 | 33.51 | 22.94 | Upgrade
|
| Operating Income | 20.24 | 23.95 | 38.7 | 47.68 | 42.19 | 39.05 | Upgrade
|
| Interest Expense | -0.74 | -0.71 | -0.86 | -1.03 | -0.6 | -0.79 | Upgrade
|
| Interest & Investment Income | 0.17 | 0.72 | 0.84 | 0.03 | 0.04 | 0.03 | Upgrade
|
| Other Non Operating Income (Expenses) | 8.1 | 2.35 | -0.03 | 1.7 | 1.03 | 0.72 | Upgrade
|
| EBT Excluding Unusual Items | 27.49 | 26.31 | 38.65 | 48.38 | 42.66 | 39 | Upgrade
|
| Other Unusual Items | 0 | - | - | -18.42 | -9.6 | - | Upgrade
|
| Pretax Income | 28.07 | 26.31 | 38.65 | 29.96 | 33.06 | 39 | Upgrade
|
| Income Tax Expense | 7.05 | 8.86 | 10.73 | 11.68 | 9.99 | 9.96 | Upgrade
|
| Earnings From Continuing Operations | 21.03 | 17.45 | 27.92 | 18.29 | 23.07 | 29.04 | Upgrade
|
| Minority Interest in Earnings | -0.29 | -0.25 | -0.36 | -0.34 | -0.13 | - | Upgrade
|
| Net Income | 20.73 | 17.2 | 27.57 | 17.94 | 22.94 | 29.04 | Upgrade
|
| Net Income to Common | 20.73 | 17.2 | 27.57 | 17.94 | 22.94 | 29.04 | Upgrade
|
| Net Income Growth | 80.92% | -37.59% | 53.63% | -21.76% | -21.03% | 30.10% | Upgrade
|
| Shares Outstanding (Basic) | 936 | 939 | 950 | 766 | 757 | - | Upgrade
|
| Shares Outstanding (Diluted) | 947 | 950 | 950 | 766 | 757 | - | Upgrade
|
| Shares Change (YoY) | 0.00% | - | 24.00% | 1.19% | - | - | Upgrade
|
| EPS (Basic) | 0.02 | 0.02 | 0.03 | 0.02 | 0.03 | - | Upgrade
|
| EPS (Diluted) | 0.02 | 0.02 | 0.03 | 0.02 | 0.03 | - | Upgrade
|
| EPS Growth | 82.97% | -36.89% | 23.89% | -22.68% | - | - | Upgrade
|
| Free Cash Flow | 8.71 | -3.85 | 1.54 | -0.01 | -4.72 | 16.63 | Upgrade
|
| Free Cash Flow Per Share | 0.01 | -0.00 | 0.00 | - | -0.01 | - | Upgrade
|
| Dividend Per Share | - | - | 0.019 | 0.019 | - | - | Upgrade
|
| Dividend Growth | - | - | 2.62% | - | - | - | Upgrade
|
| Gross Margin | 36.79% | 40.31% | 54.72% | 45.72% | 35.86% | 33.61% | Upgrade
|
| Operating Margin | 13.72% | 15.38% | 24.80% | 26.92% | 19.99% | 21.17% | Upgrade
|
| Profit Margin | 14.05% | 11.05% | 17.66% | 10.13% | 10.87% | 15.75% | Upgrade
|
| Free Cash Flow Margin | 5.90% | -2.47% | 0.99% | -0.01% | -2.23% | 9.01% | Upgrade
|
| EBITDA | 26.94 | 30.52 | 44.34 | 51.85 | 45.46 | 41.26 | Upgrade
|
| EBITDA Margin | 18.26% | 19.59% | 28.41% | 29.28% | 21.54% | 22.37% | Upgrade
|
| D&A For EBITDA | 6.7 | 6.56 | 5.64 | 4.17 | 3.28 | 2.21 | Upgrade
|
| EBIT | 20.24 | 23.95 | 38.7 | 47.68 | 42.19 | 39.05 | Upgrade
|
| EBIT Margin | 13.72% | 15.38% | 24.80% | 26.92% | 19.99% | 21.17% | Upgrade
|
| Effective Tax Rate | 25.10% | 33.67% | 27.76% | 38.97% | 30.22% | 25.54% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.